| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |